Neurological Research Institute

Santa Monica, California 90404

0 studies enrolling now · 33 studies all time

What they study most

Alzheimer's Disease, Chronic Pain, Dementia, Diabetic Neuropathy, Painful, Diabetic Peripheral Neuropathy, Drug Resistant Partial Onset Seizure, Epilepsies, Partial, Epilepsy, Epilepsy With Simple or Complex Partial Onset Seizures, Migraine, Migraine Disorders, Migraine With Aura

Studies at this site

• Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Acute Treatment Trial in Adult Subjects With Migraines — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures — Stopped early
• Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension — Completed
• Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine — Completed
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia — Completed
• Once-A-Day Pregabalin For Partial Seizures — Completed
• Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• Eslicarbazepine Acetate Monotherapy Long Term Study — Completed
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease — Completed
• Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) — Completed
• A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy — Completed
• Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed
• Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy — Completed
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) — Completed